Prostate cancer Board decisions

The Veteran's service-connected disabilities render him unable to secure or follow a substantially gainful occupation, and the Board has granted TDIU from February 8, 2017.

The Veteran's prostate cancer is presumed to be related to his exposure to herbicide agents during service, and the PACT Act of 2022 grants service connection for this condition as of October 1, 2022.

The Board has determined that additional development is necessary to determine the relationship between the Veteran's claimed conditions and his military service, particularly regarding herbicide exposure.

The Board has remanded the Veteran's claims for service connection due to incomplete development of his exposure history and dose estimates, as well as inextricably intertwined issues.

The Veteran's prostate cancer is presumed to be due to herbicide exposure in Thailand, and the claim for service connection is granted.

The Veteran's appeal for service connection for residuals of prostate cancer has been dismissed as the claim was granted in a recent rating decision. The appeals for service connection for an acquired psychiatric disability, skin disability (alopecia), heart disability, right foot disability, and left foot disability are all remanded.

The Veteran's prostate disability is rated as noncompensable due to lack of evidence of renal dysfunction or voiding dysfunction.

The Veteran's voiding dysfunction is granted a 20 percent rating from February 1, 2021 to April 27, 2021. The Veteran's erectile dysfunction and follicular lymphoma are denied higher ratings.

The Veteran's prostate cancer is granted as service connected due to exposure to herbicides while stationed at Korat Royal Thai Air Force Base in Thailand.

The Veteran's claim for increased ratings and service connection was partially granted. The rating for voiding dysfunction of prostate cancer residuals was denied prior to August 1, 2022, but a higher rating is granted beginning on that date. Service connection for left and right lower extremity peripheral neuropathy due to herbicide exposure during service was granted. A remand was ordered for further evaluation of PTSD symptoms and erectile dysfunction.

The Veteran's claim for service connection for obstructive sleep apnea was denied as it was not proximately due to or aggravated by the service-connected PTSD, coronary artery disease, and diabetes mellitus. The Veteran's prostate cancer was rated at 20% from October 1, 2012 through December 31, 2013, with a TDIU granted based on his service-connected PTSD.

The Veteran's service-connected disabilities prevent him from securing or following a substantially gainful occupation since July 1, 2020.,The Veteran submitted VA Form 21-526 for increased evaluation of heart disease, diabetes, prostate cancer residuals, and varicose veins on May 1, 2020.

The Veteran's appeal is remanded due to a duty to assist error in obtaining an inadequate examination report prior to the December 30, 2021 rating decision. The examiner did not consider the Veteran's renal dysfunction and his testimony about changing absorbent materials at least 5 times per day.

The Veteran's appeal for TDIU was denied. The appeals for service connection for colon polyps and prostate cancer were both denied.,The appeals for service connection for right knee disorder and glaucoma are pending and will be remanded.

The Veteran's service connection claims for systemic lupus erythematosus, COPD, ischemic heart disease, and prostate cancer are being remanded due to the submission of new evidence. The Board will consider the evidence submitted by the Veteran regarding exposure to toxins at Fort Wainwright, Alaska.

The Board granted service connection for metastatic prostate cancer with voiding dysfunction effective February 24, 2011, based on new evidence showing the Veteran's exposure to herbicide agents in Korea.

The Board has found the VA's decision to deny PCAFC benefits was inadequate and remanded for an updated medical review. The case is now back with the AOJ for further action.

The Veteran's service-connected prostate cancer is now rated at 60 percent effective July 27, 2020. Prior to this date, the condition was rated as non-compensable.

The appeal for prostate cancer is dismissed as the benefits have already been granted.,Service connection for hypertension has been granted based on the PACT Act.

The Veteran's service connection claims for diabetes mellitus type II and prostate cancer are granted due to presumed exposure to herbicide agents during his service in Thailand, as provided by the PACT Act.